Amplify Treatments, Testing And Advancements ETF DGX Holdings History
Number of Shares
4,115.00
Current Holdings Value*
$563,260.00
% of Portfolio
6.17%
Total Estimate Gain
$161,117.19
% of Total Estimate Gain
23.63%
Amplify Treatments, Testing and Advancements ETF's Quest Diagnostics Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 4,115.00 shares of Quest Diagnostics Inc(DGX), totaling $563,260.00. This investment constitutes 6.17% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Quest Diagnostics Inc(DGX) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $136.94 for 1,141.00 shares. Based on historical transaction data and DGX's current price of $166.91, Amplify Treatments, Testing and Advancements ETF's estimated gain on his DGX holdings is $161,117.19, reflecting a 23.63% gain to date.
Amplify Treatments, Testing and Advancements ETF DGX ($166.91) Holding Chart
Amplify Treatments, Testing and Advancements ETF DGX ($166.91) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1